Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
CD4 Count
100%
Risk Markers
100%
HIV Patients
100%
Guinea-Bissau
100%
Early Mortality
100%
Antiretroviral Therapy
85%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
71%
Soluble Form
71%
Plasma Parameters
28%
Anthropometric Measurements
28%
Viral Load
28%
Cox Proportional Hazards Model
14%
High Risk
14%
Mortality Prediction
14%
Low Body Mass Index
14%
Low-income
14%
Nave
14%
Developing Countries
14%
Triage
14%
Potential Risk Factors
14%
Antiviral Drugs
14%
Short-term Mortality
14%
Antiretroviral Therapy Initiation
14%
When to Start
14%
Low BMI
14%
Mid-upper Arm Circumference
14%
Middle-income Setting
14%
Nursing and Health Professions
Cohort Analysis
100%
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
CD4 Lymphocyte Count
100%
Urokinase Receptor
71%
Blood Level
28%
Anthropometry
28%
Virus Load
28%
Body Mass
14%
Proportional Hazards Model
14%
Triage
14%
Arm Circumference
14%
Medicine and Dentistry
Cohort Analysis
100%
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
Cell Count
85%
Urokinase Receptor
71%
Body Mass Index
28%
Anthropometry
28%
Observational Study
14%
Arm
14%
Proportional Hazards Model
14%
Triage
14%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
CD4 Lymphocyte Count
100%
Urokinase Receptor
71%
Blood Level
28%
Blood Plasma
28%
Viral Load
28%
Body Mass
14%
Arm Circumference
14%
Earth and Planetary Sciences
Guinea-Bissau
100%
Developing Country
50%